Search - tctmd.com

Displaying 1 - 20 of 1293

Sort: Relevancy | Date

News Daily News

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

L.A. McKeown

January 27, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Yael L. Maxwell

December 09, 2025

Presentation TCT 2025

Case in the Box– Venous– IVUS and Scaffold for DVT

Presenter: Erin Murphy

October 28, 2025

Presentation TCT 2025

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Presenter: Teresa L. Carman

October 28, 2025

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

Presentation TCT 2025

HOPE Registry: Updates on the 3 year results of BTK subset analyses

Presenter: Edward Tieng Chek Choke

October 28, 2025

Presentation TCT 2025

How effective is Sirolimus Coated Balloon for the treatment of PAD: SIRONA and LIMES RCT

Presenter: Dierk Scheinert

October 28, 2025

Presentation TCT 2025

A look at the peripheral DCB landscape in the US: Why is Sirolimus Coated Balloon the next big thing in PAD treatment?

Presenter: Eric A. Secemsky

October 28, 2025

Presentation TCT 2025

Going back to the beginning: the importance of pre-clinical evidence and what the data indicates for MagicTouch SCB

Presenter: Aloke Finn

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Presenter: Laurie Mobley

October 27, 2025

Presentation TCT 2025

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

CFA: Is it Still Surgery First?

Presenter: Matthew T. Menard

October 26, 2025

Presentation TCT 2025

Long Segment SFA Disease – Surgery vs. PTAB

Presenter: Ehrin J. Armstrong

October 26, 2025

Presentation TCT 2025

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Presenter: Nanchao Hong

October 26, 2025

Presentation TCT 2025

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Presenter: Brian G. DeRubertis

October 26, 2025

Presentation TCT 2025

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Presenter: Dierk Scheinert

October 26, 2025

Presentation TCT 2025

Landscape of Drug Eluting Technology for SFA

Presenter: Aloke Finn

October 26, 2025

Advertisement

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

JACC Debuts Data Digest on CV Health in the United States

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Case in the Box– Venous– IVUS and Scaffold for DVT

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Insights into PAD Pathogenesis from LIFE-BTK Substudies

HOPE Registry: Updates on the 3 year results of BTK subset analyses

How effective is Sirolimus Coated Balloon for the treatment of PAD: SIRONA and LIMES RCT

A look at the peripheral DCB landscape in the US: Why is Sirolimus Coated Balloon the next big thing in PAD treatment?

Going back to the beginning: the importance of pre-clinical evidence and what the data indicates for MagicTouch SCB

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

CFA: Is it Still Surgery First?

Long Segment SFA Disease – Surgery vs. PTAB

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Landscape of Drug Eluting Technology for SFA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content